Silver Rock Financial LP Selecta Biosciences Inc Transaction History

Silver Rock Financial LP

  • $396 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$1.5 - $4.52 $686,775 - $2.07 Million
-457,850 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$2.66 - $15.93 $875,539 - $5.24 Million
-329,150 Reduced 41.82%
457,850 $1.21 Million
Q2 2018

Aug 14, 2018
BUY
$9.36 - $13.25 $392,418 - $555,506
41,925 Added 5.63%
787,000 $0
Q1 2018

May 15, 2018
BUY
$8.49 - $11.82 $577,744 - $804,351
68,050 Added 10.05%
745,075 $0
Q3 2017

Nov 14, 2017
BUY
$15.22 - $20.03 $10.3 Million - $13.6 Million
677,025
677,025 $12.4 Million

Others Institutions Holding SELB

# of Institutions
5
Shares Held
4.67M
Call Options Held
0
Put Options Held
0
View Full List

About SELECTA BIOSCIENCES INC

SELB Quotes by TradingView
  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Silver Rock Financial LP Portfolio

Follow Silver Rock Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silver Rock Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Silver Rock Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email